United Therapeutics Insider Sold Shares Worth $4,129,608, According to a Recent SEC Filing

MT newswire2026/09/18 20:50

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:50 PM EDT, 09/18/2026 (MT Newswires) -- Paul A Mahon, Executive Vice President, General Counsel, on September 17, 2026, sold 8,300 shares in United Therapeutics (UTHR) for $4,129,608. Following the Form 4 filing with the SEC, Mahon has control over a total of 45,172 common shares of the company, with 45,172 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics Insider Sold Shares Worth $4,129,608, According to a Recent SEC Filing

You may also like

Crypto prices